Gilman Hill Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-21,590
Closed -$86K – 163
2016
Q4
$86K Hold
21,590
– – 0.03% 184
2016
Q3
$97K Hold
21,590
– – 0.04% 188
2016
Q2
$106K Sell
21,590
-75
-0.3% -$425 0.04% 180
2016
Q1
$255K Buy
+21,665
New +$301K 0.12% 140
2015
Q4
– Sell
-8,915
Closed -$216K – 178
2015
Q3
$216K Sell
8,915
-6,500
-42% -$169K 0.11% 142
2015
Q2
$392K Sell
15,415
-750
-5% -$19.9K 0.19% 107
2015
Q1
$389K Buy
16,165
+5,986
+59% +$151K 0.18% 104
2014
Q4
$228K Buy
10,179
+2,487
+32% +$64.7K 0.12% 139
2014
Q3
$211K Hold
7,692
– – 0.11% 142
2014
Q2
$245K Buy
+7,692
New +$229K 0.13% 131

Other funds holding CLMT

Gilman Hill Asset Management's CLMT Position: Q1 2017 in Review

Gilman Hill Asset Management sold out of Calumet Specialty Products (CLMT) in Q1 2017, closing a stake of 21,590 shares — an estimated $86K sold.

Gilman Hill Asset Management first reported a position in CLMT in Q2 2014 and held it in 10 quarters. The position peaked at $392K in Q2 2015. 68 funds tracked by Wall St. Rank hold CLMT as of Q1 2017.

  • Gilman Hill Asset Management reported no remaining Calumet Specialty Products position as of Q1 2017 after selling out during the quarter.
  • Gilman Hill Asset Management sold 21,590 Calumet Specialty Products shares in Q1 2017, an estimated $86K.
  • Gilman Hill Asset Management first reported a position in Calumet Specialty Products in Q2 2014 and held it in 10 quarters.
  • Gilman Hill Asset Management's Calumet Specialty Products position peaked at $392K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2017.

Based on Gilman Hill Asset Management's 13F filing for Q1 2017, filed 24 Apr 2017.